Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
32
33
Next >
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
Market News
BIIB
Health Care
From
Benzinga
3 Healthcare Stocks That Could Help Set You Up for Life
April 07, 2022
Tickers
BIIB
GMED
LLY
SGEN
Tags
BIIB
GMED
Market News
From
Motley Fool
Could Amylyx Pharmaceuticals Have a Blockbuster ALS Treatment?
March 29, 2022
Tickers
AMLX
BIIB
Tags
Recent Press Releases
Market News
BIIB
From
Motley Fool
Ionis-Biogen Partnered Amyotrophic Lateral Sclerosis Trial Disappoints
March 28, 2022
Tickers
BIIB
IONS
Tags
General
IONS
Briefs
From
Benzinga
Is Johnson & Johnson Setting a Dangerous Precedent for the Healthcare Industry?
March 26, 2022
Tickers
BIIB
JNJ
MRNA
OCGN
Tags
Market News
Recent Press Releases
JNJ
From
Motley Fool
Why I Sold Kohl’s Corporation Despite Possible Buyout Deal
March 22, 2022
Tickers
BIIB
KSS
NLSN
Tags
Stocks to Sell
NLSN
KSS
From
InvestorPlace
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Market News
BIIB
Health Care
From
Benzinga
2 Red Flags for Biogen's Future
March 22, 2022
Tickers
BIIB
LLY
Tags
Recent Press Releases
Market News
LLY
From
Motley Fool
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
Biotech
Alzheimer's disease
Benzinga
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Market News
Contracts
General
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
IMRA
ESALY
BTTX
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
News
Briefs
Biotech
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
March 08, 2022
Tickers
ACET
ACTD
ALEC
AREN
Tags
Intraday Update
RGF
FULC
From
Benzinga
10 Biggest Price Target Changes For Tuesday
March 08, 2022
Tickers
AUPH
AVDX
BBBY
BIIB
Tags
WLL
AUPH
CARA
From
Benzinga
As President Biden proposed, Medicare needs the ability to negotiate drug prices
March 07, 2022
Tickers
BIIB
Tags
BIIB
From
MarketWatch
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
March 04, 2022
Tickers
BIIB
CEMI
ESALY
EYEN
Tags
News
Penny Stocks
Earnings
From
Benzinga
Why This Analyst Sees Roughly 20% Upside In This Large-Cap Biopharma
March 03, 2022
Tickers
BIIB
Tags
Analyst Ratings
BIIB
Analyst Color
From
Benzinga
Expert Ratings For Biogen
March 03, 2022
Tickers
BIIB
Tags
BZI/AAR
BIIB
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Tickers
ALGT
AORT
AVTX
BALY
Tags
BRT
TER
QRVO
From
Benzinga
10 Biggest Price Target Changes For Thursday
March 03, 2022
Tickers
AEO
AI
BHG
BIIB
Tags
Pre/Market Outlook
COP
BLL
From
Benzinga
Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver
February 28, 2022
Tickers
BIIB
PFE
VTRS
Tags
VTRS
BIIB
PFE
From
MarketWatch
Medicare’s finances and the saga of the Alzheimer’s drug Aduhelm
February 24, 2022
Tickers
BIIB
Tags
BIIB
From
MarketWatch
What Investors Can Learn From Biogen's Drug Approval That No One Wants
February 23, 2022
Tickers
BIIB
Tags
BIIB
Market News
Recent Press Releases
From
Motley Fool
Could Advocacy Groups' Campaign for Aduhelm Benefit Biogen?
February 19, 2022
Tickers
BIIB
Tags
BIIB
Market News
Recent Press Releases
From
Motley Fool
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
Tickers
AFRM
AGNC
AHI
ALGS
Tags
SOND
WORX
BEAT
From
Benzinga
Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study
February 16, 2022
Tickers
BIIB
SAGE
Tags
Benzinga
Phase 3 Trial
Movers
From
Benzinga
US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time
February 16, 2022
Tickers
BIIB
BNTX
PFE
Tags
FDA
General
Biotech
From
Benzinga
3 Red Flags for Biogen's Future
February 16, 2022
Tickers
BIIB
Tags
Recent Press Releases
Market News
BIIB
From
Motley Fool
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
February 16, 2022
Tickers
ALKS
AMGN
ATXI
AVNS
Tags
General
Small Cap
GBT
From
Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
Tickers
ARVN
BIIB
CCCC
GOOG
Tags
SNY
PFE
KYMR
From
Motley Fool
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.